Cowen Financial Products LLC - Jun 30, 2025 SCHEDULE 13G/A Report for Stoke Therapeutics Inc Common Stock (STOK)

Filing Manager: Cowen Financial Products LLC
Reporting Manager: Cowen Financial Products LLC
Security: Stoke Therapeutics Inc Common Stock
Symbol: STOK
Shares outstanding: 54.7M shares
Disclosed Ownership: 3.17M shares
Ownership: 5.8%
Form type: SCHEDULE 13G/A
Date filed: 7/29/2025, 05:11 PM
Date of event: Jun 30, 2025
Next filing: Nov 14, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Cowen Financial Products LLC	5.8%	3.17M	3.17M	0	John Holmes	John Holmes / Chief Operating Officer